Pune, Maharashtra -- (SBWire) -- 02/19/2019 --This Fact.MR report on the global peptide based cardiovascular therapeutics market forecasts that the global peptide based cardiovascular therapeutics market will touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
North America Market Set to Dominate the Global Peptide Based Cardiovascular Therapeutics Market in Terms of Revenue
The market in North America is set to dominate the global peptide based cardiovascular therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based cardiovascular therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=191
Bivalirudin Segment Poised to Touch a Value of Nearly US$ 1,360 Mn in 2022
As per the forecast of Fact.MR, the bivalirudin segment is expected to reach a value of nearly US$ 1,360 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Bivalirudin segment is expected to account for more than two-third of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.
Hospital Pharmacies Segment to exhibit a CAGR of 8.9% During the Assessment Period
As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 960 Mn in the year 2022. This represents a CAGR of 8.9% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.
Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=191
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global peptide based cardiovascular therapeutics market through 2022, which include AstraZeneca, plc, Corden Pharma GmbH, Ipsen S.A, Merck & Co., Inc., Pfizer Inc, Apotex Holdings, Inc., Dr. Reddy's Laboratories Limited, Fresenius Kabi USA, LLC, Novetide Ltd and Amneal Pharmaceuticals LLC.
Therapeutic peptides are used in the treatment of cardiovascular disorders that are a leading cause of mortality and morbidity throughout the world. Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. Such type of covalent chemical bonds are formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are differentiated from proteins on the basis of size, and peptides contain 50 amino acids or less approximately.
Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=191
Detailed TOC of Global Peptide Based Cardiovascular Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
1. Global Peptide Based Cardiovascular Therapeutics Market - Executive Summary
2. Global Peptide Based Cardiovascular Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Cardiovascular Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Cardiovascular Therapeutics Market Definition
2.2. Global Peptide Based Cardiovascular Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Cardiovascular Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Cardiovascular Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Access This Report @ https://www.factmr.com/checkout/191/S
3. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Bivalirudin Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Eptifibatide Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
4. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Distribution Channel
4.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
4.1.1. Hospital Pharmacies Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Retail Pharmacies Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Online Pharmacies Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
5. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.1. North America Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Drug
5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.2. Latin America Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Drug
5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.3. Europe Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.3.1. Revenue (US$ Mn) Comparison, By Drug
5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.4. Japan Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.4.1. Revenue (US$ Mn) Comparison, By Drug
5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.5. APEJ Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.5.1. Revenue (US$ Mn) Comparison, By Drug
5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.6. MEA Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022
5.1.6.1. Revenue (US$ Mn) Comparison, By Drug
5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel
And Contnue...
List of Figures, Tables and Charts Available in Global Peptide Based Cardiovascular Therapeutics Market 2017 by Manufacturers, Regions, Type and Application, Forecast to 2022
TABLE 1 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Bivalirudin Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Bivalirudin Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Bivalirudin Segment Market Share, By Region 2012-2016
TABLE 7 Global Bivalirudin Segment Market Share, By Region 2017-2022
TABLE 8 Global Bivalirudin Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Eptifibatide Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Eptifibatide Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Eptifibatide Segment Market Share, By Region 2012-2016
TABLE 12 Global Eptifibatide Segment Market Share, By Region 2017-2022
TABLE 13 Global Eptifibatide Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017-2022
And Continue...
FIG. 1 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Cardiovascular Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Bivalirudin Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Bivalirudin Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Bivalirudin Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Eptifibatide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Eptifibatide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Eptifibatide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
And Continue...
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://theswisstimes.com
Peptide Based Cardiovascular Therapeutics Market Show Steady Growth: Study
Fact.MR has announced the addition of the “ Peptide Based Cardiovascular Therapeutics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028"report to their offering.